Advertisement

Pharmacy World and Science

, Volume 27, Issue 3, pp 230–235 | Cite as

Outpatient Use of Systemic Antibiotics in Croatia

  • D. Štimac
  • I. VukušićEmail author
  • J. Čulig
Article

Abstract

Objective: The aim was to estimate the outpatient utilization of antibacterials for systemic use in Zagreb, Croatia, and to define the antibiotic utilization characteristics and consequences.

Method: Using the WHO ATC/DDD methodology, the number of defined daily doses per 1000 inhabitants per day (DDDs/TID) was calculated for each individual antibiotic and ATC system levels were calculated from data collected on the number and size of packages prescribed and dispensed from pharmacies. The Drug Utilization 90% (DU90%) method was used to evaluate the quality of drug prescribing.

Results: The total utilization of antibiotics was found to be extremely high, 55.0 DDDs/TID. The leading antibiotic was amoxicillin + clavulanic acid with 14.7 DDDs/TID. Penicillins accounted for the highest utilization (46.3%) expressed in DDDs/TID (25.4), followed by cephalosporins and macrolides 25 and 12.5% of utilization, respectively expressed in DDDs/TID), tetracyclines, quinolones, aminoglycosides and other agents. Nine of 27 antibiotics fell within the DU90% segment. The cost/DDD foldrugs within DU90% segment was 1.2 EUR, for drugs beyond DU90% segment was 1.4 EUR, and the average was 1.2 EUR.

Conclusion: Irrational prescribing and preference to more expensive drugs have been reported in Zagreb. Therefore, the risk of resistance of microorganisms to beta-lactamase antibiotics, macrolides and quinolones could be expected. Prescribing patterns should be changed by introducing national guidelines on rational antibiotic prescribing, monitoring and evaluation of their implementation. Additional continuing education of physicians and pharmacists from independent sources should be organized and proper education should be provided to patients.

Keywords

Antibiotics systemic ATC/DDD methodology Croatia Drug utilisation Outpatient 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Vrhovac, B, Reiner, Ž. 2000Handbook of pharmacotherapy3Med-Ekon d.d.ZagrebISBN 953-9699-7-5 [in Croatian]Google Scholar
  2. Drug Commission of “Dr. Fran Mihaljević”, University hospital of infectious diseases zagreb. Guidelines for antimicrobial treatment of urinary infections, 2002 [in Croatian]. Available at: http:/www.cromed.hr/clanci/infektologija/volume1/pocetak.asp (22 May 2003)Google Scholar
  3. Schönwald, S, Baršić, B. 2001Pocket handbook of treatment and prevention of infectious diseasesBirotisakZagrebISBN 953-98132-0-4 [in Croatian]Google Scholar
  4. Croatian Institute of Health Insurance.2003List of prescription drugsOfficial J602176[in Croatian]Google Scholar
  5. Intercontinental Marketing Service. Sales Force Effectiveness, 15 August 2001. Available at: http://www.ims-global.com/ insight.htm (22 June 2003)Google Scholar
  6. Hrastić-Novak L, Janiček M. (Analysis of drug consumption in 2002. Abstract Book of The XVI Annual Convention of Pharmacists. Hvar: 15–18 May 2003; 27–9 [in Croatian]Google Scholar
  7. Vinter-Repalus, N, Jelić, J. 2003Through education of physicians to rational drug prescribingLijećnićke Novine17134[in Croatian]Google Scholar
  8. Anatomical Therapeutic Chemical (ATC). (2002). Classification Index with Defined Daily Doses (DDDs). January 2002. WHO Collaborating Centre for Drug Statistics Methodology, OsloGoogle Scholar
  9. Merlo, J, Wessling, A, Melander, A. 1996Comparison of dose standard units for drug utilization studiesEur J Clin Pharmacol502730CrossRefPubMedGoogle Scholar
  10. Bergman, U, Popa, C, Tomson, Y, Wettermark, B, Einarson, TR, Aberg, H, Sjoqvist, F. 1998Drug utilization 90% – a simple method for assessing the quality of drug prescribingEur J Clin Pharmacol541138PubMedGoogle Scholar
  11. Vlahovic-Palcevski, V, Wettermark, B, Bergman, U. 2002Quality of non-steroidal anti-inflammatory drug prescribing in Croatia (Rijeka) and Sweden (Stockholm)Eur J Clin Pharmacol5820914PubMedGoogle Scholar
  12. National Agency for Medicines,Finland (2002) Drug Consumption Statistics, 2002. Available at: http:// www.nam.fi/english/information/drug consumption/index.html (19 February 2003)Google Scholar
  13. Cars, O, Mölstad, S, Melander, A. 2001Variation in antibiotic use in the European UnionLancet35718513CrossRefPubMedGoogle Scholar
  14. Rønning, M, Blix, HS, Strøm, H, Skovlund, E, Andersen, R, Stichele, RV. 2003Problems in collecting comparable national drug use data in Europe: the example of antibacterialsEur J Clin Pharmacol588439PubMedGoogle Scholar
  15. Natsch, S, Hekster, YA, Jong, R, Heerdink, ER, Herings, RMC, Meer, JWM. 1998Application of the ATC/DDD Methodology to Monitor Antibiotic Drug UseEur J Clin Microbiol Infect Dis17204CrossRefPubMedGoogle Scholar
  16. Björnsdóttir, I, Hansen, EH, Grímsson, A. 1999Quality assessment of drug sales data: the case of antibacterials in IcelandPharm World Sci212216CrossRefPubMedGoogle Scholar
  17. Seppälä, H, Klaukka, T, Vuopio-Varkila, J, Muotiala, A, Helenius, H, Lager, K,  et al. 1997The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A Streptococci in FinlandN Engl J Med3374416CrossRefPubMedGoogle Scholar
  18. Bergman, U, Herxheimer A, . 1993Drug utilization research in EuropeLancet342167CrossRefGoogle Scholar
  19. Melander A. Variation in Drug Utilisation in the EU: Causes and Consequences as Illustrated by Antibiotics. Conference on Perspectives and Achivements with Rational Pharmacotherapy, Copenhagen, 6 November 2002. 15. September 2003. Available at: http://www.irf.dk/dk/temasektion/perspectives_and_ achivements_in_rational_pharma.htm (13 November 2003)Google Scholar
  20. Bronzwaer, SLAM, Cars, O, Buchholz, U, Mölstad, S, Goettsch, W, Veldhuijzen, IK,  et al. 2002A European study on the relationship between antimicrobial use and antimicrobial resistanceEmerg Infect Dis827882PubMedGoogle Scholar
  21. McCraig, FL, Besser, ER, Hughes, MJ. 2003Antimicrobial drug prescriptions in ambulatory care settings – United StatesEmerg Infect Dis9457Google Scholar
  22. Popova, M, Popova, P, Guencheva, G. 1997Consumption of anti-infective drugs in Bulgaria for the period from 1979 to 1994Pharm World Sci19939CrossRefPubMedGoogle Scholar
  23. Bremón, AR, Ruiz-Tovar, M, Gorricho, BP, Díazde Torres, P, Rodríguez, RL. 2000Non-hospital consumption of antibiotics in Spain: 1987–1997J Antimicrob Chemother45395400CrossRefPubMedGoogle Scholar
  24. Austin, DJ, Kristinsson, KG, Anderson, RM. 1999The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistanceProc Natl Acad Sci USA9611526CrossRefPubMedGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  1. 1.Zagreb Institute of Public HealthZagrebCroatia

Personalised recommendations